AAS
GMAB icon

Avantax Advisory Services’s Genmab GMAB Stock Holding History

Avantax Advisory Services’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.48M Sell
71,635
-759
-1% -$15.6K 0.01% 947
2025
Q1 		$1.42M Buy
+72,394
New +$1.52M 0.01% 923

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Avantax Advisory Services's GMAB Position: Q2 2025 in Review

Avantax Advisory Services reduced its Genmab (GMAB) stake by 1% in Q2 2025, selling an estimated $15.6K and leaving 71,635 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #947.

Avantax Advisory Services first reported a position in GMAB in Q1 2025 and has held it in 2 quarters since. 218 funds tracked by Wall St. Rank hold GMAB as of Q2 2025.

  • Avantax Advisory Services held 71,635 shares of Genmab worth $1.48M as of Q2 2025.
  • Avantax Advisory Services sold 759 Genmab shares in Q2 2025, an estimated $15.6K.
  • Genmab made up 0.01% of Avantax Advisory Services's portfolio in Q2 2025, its #947 holding.
  • Avantax Advisory Services first reported a position in Genmab in Q1 2025 and has held it in 2 quarters since.
  • 218 funds tracked by Wall St. Rank held Genmab as of Q2 2025.

Based on Avantax Advisory Services's 13F filing for Q2 2025, filed 8 Aug 2025.